BSECompany Update12 Aug 2026 · 12 Aug 2026, 05:07 pm
Update on Investor Conference
Zydus Lifesciences Ltd · 532321
✦ AI Summary
Zydus Lifesciences Ltd has rescheduled its participation in the Motilal Oswal 22nd Annual Global Investor Conference from August 18 to August 17, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
cfafc7ca-82f8-4e9d-862c-5de3879a9737.pdf
View document text
August 12, 2026
Listing Department Code: 532321
BSE LIMITED
P J Towers, Dalal Street,
Mumbai-400 001
Listing Department Code: Zyduslife
NATIONAL STOCK EXCHANGE OF INDIA LIMITED
Exchange Plaza, C/1, Block G,
Bandra-Kurla Complex,
Bandra (E),
Mumbai-400 051
Re.: Update on Investor Conference
Ref: Our earlier intimation dated August 10, 2026
In our earlier intimation dated August 10, 2026, Zydus Lifesciences Limited (the “Company”)
had informed about the participation of the Company in Motilal Oswal 22nd Annual Global
Investor Conference, 2026 on August 18, 2026.
We hereby inform that the said Investor Conference has been rescheduled to be now held on
August 17, 2026. In view of the same, the Company will participate in the said Investor
Conference on August 17, 2026.
Please bring the aforesaid update to the notice of the members of the exchange and the
investors’ at large.
Thanking you,
Yours faithfully,
For, ZYDUS LIFESCIENCES LIMITED
DHAVAL N. SONI
COMPANY SECRETARY AND COMPLIANCE OFFICER
MEMBERSHIP NO. FCS7063